The roadmap

Where TitrateLab is going.

Research publishes now. Order routing opens after regulatory clarity. Data depth expands continuously. The staging below is how we're sequencing the build — reviewed as regulatory and supply-chain conditions change.

Timeline
  1. Now

    Research, chat, and Pro

    Research publishes continuously. The /chat citation-first assistant is live against the production corpus. The platform is open — create a free account to read the full corpus, or go Pro for $33 once (lifetime). Everyone still earns lifetime Pro after $1k routed.

  2. Q3 2026 (post-PCAC)

    Order routing services open

    One-click multi-vendor carts, transparent batch selection, and the flat consolidation fee described on /pricing. Ships behind regulatory clarity in the US FDA's Pharmacy Compounding Advisory Committee (PCAC) consultation window.

  3. Q4 2026

    Public leaderboards and deeper compound coverage

    Public vendor leaderboard. Community sentiment dashboard surfacing forum and chat signal alongside COA data. Expanded compound coverage — starting with BPC-157 and TB-500 depth parity to the existing GLP-1 / GHRH archives.

  4. 2027

    Additional sources and multi-jurisdiction coverage

    Meso, excelmale, and promuscle ingested into the forum corpus. Discord archive folded into the public research surface. Multi-jurisdiction coverage (UK, EU, CA) with jurisdiction-specific pricing and routing logic.

Principle Dates are aspirational. Regulatory and supply-chain shifts take priority over the schedule; we'll update this page as they happen rather than let it go stale.
NOW OPEN

TitrateLab is open.

Create a free account to read the full corpus and run the COA tools. Go Pro for $33 once — lifetime, launch pricing.

Pro · $33 lifetime launch pricing — see what's included. Free accounts read the full corpus and run the COA tools.